NCT01663181

Brief Summary

At an academic tertiary referral center, patients with pelvic floor dysfunction, scheduled for outpatient cystoscopy or urodynamic testing will be asked to participate in the study. Patients will be called one day after the examination and will be asked about pain and their general state of health. The purpose of this study it to investigate pain perception in urogynecologic patients during outpatient cystoscopy and compare it with pain perception during outpatient urodynamic. The investigators will also investigate the difference between anticipated and actual pain perception. The investigators will test the null hypothesis that there is no difference in patients´ pain perception between outpatient cystoscopy and urodynamic testing. The secondary hypothesis will be that there is no difference between patients´ anticipated amount of pain and the actually experienced pain during cystoscopy and urodynamic testing. According to power calculation, a sample size of 52 patients per group will be needed to detect a 2 cm difference in pain scores on the VAS - judged as a clinically significant difference - with 95% power and a two-sided significance level of 0.05. Exclusion criteria are: age ≤ 18 years, insufficient ability to understand German, pregnancy and the participation in another clinical study at the same time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
109

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2009

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2010

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

August 5, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 13, 2012

Completed
Last Updated

April 12, 2022

Status Verified

April 1, 2022

Enrollment Period

9 months

First QC Date

August 5, 2012

Last Update Submit

April 8, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • subjective pain perception immediately after examination as measured by a standard visual analog scale

    patients are assessed at three points in time: 1. zero to ten minutes before undergoing examination 2. zero to ten minutes after undergoing examination 3. 24 hours after undergoing examination

    immediately after examination (zero to ten minutes after completing cystoscopy or urodynamics)

Secondary Outcomes (1)

  • difference between anticipated pain and actual pain perception

    immediately before and immediately after the examination (zero to ten minutes after undergoing examination)

Study Arms (2)

urogynecologic patients undergoing outpatient cystoscopy

urogynecologic patients undergoing outpatient-urodynamics

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

women, aged \>= 18 years with pelvic floor dysfunction, undergoing diagnostic work-up at a tertiary referral center for urogynecologic conditions

You may qualify if:

  • women undergoing cystoscopy or urodynamic testing at an academic tertiary referral center.

You may not qualify if:

  • age ≤ 18 years
  • insufficient ability to understand German
  • pregnancy
  • participation in another clinical study at the same time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University Vienna

Vienna, 1090, Austria

Location

MeSH Terms

Conditions

Urinary IncontinenceUrinary Bladder, OveractivePelvic Organ ProlapseUrinary Tract Infections

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsUrinary Bladder DiseasesProlapsePathological Conditions, AnatomicalInfections

Study Officials

  • Wolfgang Umek, Prof

    Medical University Vienna Austria

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ao.Univ.Prof.Dr.univ.med

Study Record Dates

First Submitted

August 5, 2012

First Posted

August 13, 2012

Study Start

May 1, 2009

Primary Completion

February 1, 2010

Study Completion

April 1, 2010

Last Updated

April 12, 2022

Record last verified: 2022-04

Locations